Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir”-Reference-Cited by-同舟云学术

Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir”

Published:2018-07-05 Issue:3 Volume:9 Page:
ISSN:2161-2129
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Malet Isabelle¹,Subra Frédéric²,Richetta Clémence²,Charpentier Charlotte³,Collin Gilles³,Descamps Diane³,Calvez Vincent¹,Marcelin Anne-Geneviève¹,Delelis Olivier²

Affiliation:

1. Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié Salpêtrière, Laboratoire de Virologie, Paris, France

2. LBPA, ENS Cachan, CNRS UMR 8113, IDA FR3242, Université Paris-Saclay, Cachan, France

3. IAME, UMR1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Hôpital Bichat, Laboratoire de Virologie, Paris, France

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mBio.00623-18

Reference18 articles.

1. Novel secondary mutations C56S and G149A confer resistance to HIV-1 integrase strand transfer inhibitors

2. Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance

3. Combination of two pathways involved in raltegravir resistance confers dolutegravir resistance